Association of Thyroid Function with Metabolic Parameter in IDD Clinic Patients, Magelang Research and Development Center (original) (raw)

2021, Medico-Legal Update

Abstract

Metabolic parameters, such as lipid and glucose metabolism, blood pressure, and body weight, are influenced by thyroid hormones. Thyroid dysfunction may lead to the development of the metabolic syndrome. The study aimed to analyze the relationship between thyroid dysfunction and metabolic parameters in IDD clinic patients, Magelang Research and Development Center. A cross-sectional study of 83 patients who met the inclusion and exclusion criteria. Total cholesterol, LDL, HDL, TSH, and free T4 concentration had been measured in all subjects. BMI and blood pressure were measured. Concentrations of lipids, triglycerides, free T4, and TSH were analyzed. The mean age of the patient was 33.5 ± 8.6 of whom 6 (7.2 %) subclinical hypothyroidism, 17 (20.5 %) overt hyperthyroidism, and 17 (20.5 %) had subclinical hyperthyroidism. There was positive relationship between TSH and systolic; whereas, FT4 was associated with BMI, systole, and diastole after adjustment for age. Overt hyperthyroidism had significantly higher odds of hypertension after adjustment for age and BMI (OR 5.557 (1.310-23.578), p<0.05). Hyperthyroidism may induce hypertension.

Figures (5)

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (22)

  1. Jang J, Kim Y, Shin J, Lee SA, Choi Y, Park EC. Association between thyroid hormones and the components of metabolic syndrome. BMC Endocr Disord. 2018;18(1):1-9.
  2. Delitala AP, Fanciulli G, Maioli M, Delitala G. Subclinical hypothyroidism, lipid metabolism and cardiovascular disease. Eur J Intern Med [Internet]. 2017;38:17-24. Available from: http://dx.doi. org/10.1016/j.ejim.2016.12.015
  3. Åsvold BO, Bjøro T, Nilsen TIL, Vatten LJ. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: A population-based study. J Clin Endocrinol Metab. 2007;92(3):841₂5.
  4. Bjergved L, Jørgensen T, Perrild H, Laurberg P, Krejbjerg A, Ovesen L, et al. Thyroid function and body weight: A community-based longitudinal study. PLoS One. 2014;9(4):7₂13.
  5. Mehran L, Amouzegar A, Rahimabad PK, Tohidi M, Tahmasebinejad Z, Azizi F. Thyroid Function and Metabolic Syndrome: A Population-Based Thyroid Study. Horm Metab Res. 2017;49(3):192- 200.
  6. Yu S, Guo X, Yang H, Zheng L, Sun Y. An update on the prevalence of metabolic syndrome and its associated factors in rural northeast China. BMC Public Health. 2014;14(1):1-9.
  7. Danzi S, Klein I. Thyroid Hormone and the Cardiovascular System. Med Clin North Am [Internet]. 2012;96(2):257-68. Available from: http://dx.doi.org/10.1016/j.mcna.2012.01.006
  8. Berta E, Lengyel I, Halmi S, Zrínyi M, Erdei A, Harangi M, et al. Hypertension in thyroid disorders. Front Endocrinol (Lausanne). 2019;10(JULY): 1-11.
  9. Rivas AM, Pena C, Kopel J, Dennis JA, Nugent K. Hypertension and Hyperthyroidism: Association and Pathogenesis. Am J Med Sci [Internet]. 2020;1- 5. Available from: https://doi.org/10.1016/j. amjms.2020.08.012
  10. Duntas LH, Brenta G. The Effect of Thyroid Disorders on Lipid Levels and Metabolism. Med Clin North Am [Internet]. 2012;96(2):269-81. Available from: http://dx.doi.org/10.1016/j. mcna.2012.01.012
  11. Irwin Klein KO. Hormone Action. N Engl J Med. 2011;344(7):501-9.
  12. Nurcahyani YD, Sukandar PB, Fitriyanto RE, Akhmad SA. Relationship between thyroid hormone and lipid profile in patients with struma at the iodine deficiency disorder (IDD) clinic of research and development center Magelang. J Kedokt dan Kesehat Indones. 2020;11(2):130-40.
  13. Ogston SA, Lemeshow S, Hosmer DW, Klar J, Lwanga SK. Adequacy of Sample Size in Health Studies. Biometrics. 1991;47(1):347.
  14. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International . Circulation. 2009;120(16):1640-5.
  15. Baloch Z, Carayon P, Conte-Devolx B. Guidelines Commitee. National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid diseases. Thyroid. 2003;13:3-126.
  16. Neves JS, Vale C, Have M von, Borges-Canha M, Leite AR, Almeida-Coelho J, et al. Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction. Ther Adv Endrocinology Metab. 2020;11:1-12.
  17. Siu CW, Yeung CY, Lau CP, Kung AWC, Tse HF. Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Heart. 2007;93(4):483-7.
  18. Gropper SS, Smith JL, Carr TP. Advanced Nutrition and Human Metabolism. Seventh. Boston: Cengage Learning; 2018. 528-533 p.
  19. Hönes GS, Rakov H, Logan J, Liao XH, Werbenko E, Pollard AS, et al. Noncanonical thyroid hormone signaling mediates cardiometabolic effects in vivo. Proc Natl Acad Sci U S A. 2017;114(52):E11323- 32.
  20. Mayyas F, Saadeh N, Al-Muqbel K, Van Wagoner DR. Plasma endothelin-1 levels are increased in atrial fibrillation patients with hyperthyroidism. PLoS One. 2018;13(12):1-13.
  21. Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension. J Clin Hypertens (Greenwich). 2006;8(8):596-9.
  22. Li JH, Kasid N, Hennessey J V. Graves' Disease. In: Luster M, Duntas LH, Wartofsky L, editors. The Thyroid and its Diseases -A Comprehensive Guide for the Clinician 1st Edition. 1st ed. Springer International Publishing; 2019.